Regulators squeezed in two final approvals before the calendar change with the UK approval of Merck’s Winrevair and the FDA’s ...
Seek expert support for respiratory issues from pulmonologists. Learn how they diagnose and manage lung diseases for better ...
Patna: With a plunge in temperature in the last few days, city hospitals have been witnessing rise in cases related to heart ...
Medically reviewed by Angela Ryan Lee, MD Heart failure occurs when the heart can't pump blood as well as it should. It can ...
Health on MSN6d
What To Know About Valvular Heart DiseaseMedically reviewed by Rafle Fernandez, MD Valvular heart disease, sometimes called heart valve disease, is when one or more ...
MedPage Today on MSN5d
Have the New Pulmonary Hypertension Drugs Changed the Game?After the FDA approved both combination macitentan/tadalafil (Opsynvi) and the biologic therapy sotatercept (Winrevair) for ...
Low birth weight is associated with an increased risk of chronic obstructive pulmonary disease (COPD), particularly among ...
Increasing average concentrations of sotatercept improved 6-minute walk distance, pulmonary vascular resistance, and levels of NT-proBNP.
GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of ...
Aug. 22, 2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary ... which causes potentially life-threatening symptoms in millions of Americans with lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback